News

  • EYETRONIC data from Spain presented at the annual meeting of the Spanish Society of Glaucoma 2026 in Toledo, March 2026

On the occasion of the annual meeting of the Spanish Society of Glaucoma 2026 in Toledo about two weeks ago, Dr. Lucia Rial Álvarez, from the Vissum Oftalmología Eye Clinic in Alicante, presented the results of non-invasive optic nerve stimulation with Eyetronic.

Data from 60 patients - 18 patients treated in A Coruña at the Gutiérrez Amoros Vista center (by Dr. Carlos Gutiérrez Amorós) and 42 patients from the Vissum Eye Center in Alicante - were presented.

69% of all treated eyes showed stable or improved visual fields at 3 months follow-up. Of the 24 patients with 9-month follow-up, an even higher clinical benefit was observed, with 75% showing stable or improved visual fields.

  • 3-month follow-up EYETRONIC data from Poland presented at the Glaucoma 360 New Horizins Forum, January 2026

On the occasion of the Glaucoma 360 New Horizons Forum in San Francisco on January 30, Prof. Adrian Smedowski MD, PhD, FEBO, Medical University of Silesia, Katowice, Poland, shared also 3-month follow-up data from 50 patients as part of the panel „Breaking Barriers in Glaucoma: Neuroprotection & Vision Restoration“.

Prof. Smedowski presented the improvements of this patient group in several key parameters, including visual field, contrast and acuity, after having been treated with EYETRONIC at his Glaucomed Clinic in Bytom.

For more information about the center in Bytom feel free to also visit the website: https://www.glaucomed.pl/

  • First EYETRONIC US Data presented at the Glaucoma 360 New Horizins Forum, January 2026

For the first time, clinical experience gathered in the United States with EYETRONIC non-invasive optic nerve stimulation was presented earlier this year.

On January 30, the Glaucoma Research Foundation, the largest philanthropic glaucoma organization, gathered world-leading experts at its annual Glaucoma 360 New Horizons Forum in San Francisco. Under the title „Breaking Barriers in Glaucoma: Neuroprotection & Vision Restoration“ latest developments in treating glaucoma were presented.

The panel was moderated by Prof. Jeffrey Goldberg, Stanford University and Dr. Sunita Radhakrishnan from the Glaucoma Center of San Francisco (GCSF, Executive Director: Dr. Andrew Iwach) shared the experiences with EYETRONIC® from the trials conducted at the GCSF and at Stanford University.

  • EYETRONIC Presentation at the 45th Workshop Glaucoma, January 2026

We are very happy that we had been a part of the 45th Workshop Glaucoma in January 2026 from Carl Erb, MD, PhD.

Attached you can find a presentation about the Eyetronic Therapy.

  • First EYETRONIC therapy center starting in Greece (Athens) November 2025

We are excited to announce the start of Eyetronic in Greece!

Early November 2025 the clinic OMMA - OFTHALMOLOGIKO INSTITOUTO ATHINON S.A. in Athens from Dr. Chaidouls Stelios (Head of glaucoma department) and Dr. Ioannis Datserisn startet with EYETRONIC!

Feel free to contact OMMA at: info@omma.gr or take a look at their website: https://www.ommaofthalmologikokentro.gr/

Furthermore we would like to welcome our local distributor Ocular Quality Services (OQS) to support us in Greece!

If you have any questions about Eyetronic in Greece, please feel free to contact our partner OQS also at: info@oqs.gr

In addition to that we would like to thank the team of Adrian Smedowski MD, PhD, FEBO for their on-site support!

  • Further patients beeing treated with EYETRONIC in the U.S. as part of a clinical study at Stanford University, July 2025

We are very excited to announce that in July 2025 also Stanford University started their clinical trial with EYETRONIC!

We highly appreciate the work of the Spencer Center for Vision Research, run by Prof. Dr. Jeffrey Goldberg, MD, PhD as well as his whole team involved, including Zachary Wennberg-Smith.

For further information you might also contact them at: zacwenn@stanford.edu

  • First Patient beeing treated with EYETRONIC in the U.S. as part of a clinical study at the Glaucoma Center of San Francisco, July 2025

We are very excited to announce the first treatment of a patient in the U.S. with EYETRONIC!

Mid July 2025 the first patient has started the Eyetronic treatment as part of a clinical trial at the Glaucoma Center of San Francisco, one of the largest stand-alone glaucoma clinics on the West Coast.

We highly appreciate the work of the Glaucoma Center of San Francisco, run by Executive Director Andrew Iwach, MD as well as the whole team involved, including the Principal Investigator of the study: Sunita Radhakrishnan, MD.

For further information you might also contact them at: research@GlaucomaSF.com

We are very happy to share also those two press releases about this milestone:

PR Newswire: New Non-Invasive Glaucoma Treatment Offered for First Time in U.S.

Yahoo Finance: New Non-Invasive Glaucoma Treatment Offered for First Time in U.S.

  • Poster Presentation of the newest Eyetronic data regarding progressive glaucoma patients at the 11th World Glaucoma Congress (WGC) on Hawaii, U.S., June 2025

We are very happy to share the poster shown on at the World Glaucoma Congress on Hawaii in June 2025, presenting our latest data of progressive glaucoma patients being treated with Eyetronic.

About 2/3 of the treated patients are responders!

Following you can find the poster:

  • Second Eyetronic Therapy center in Spain (Alicante)

We are very happy to share the news that since the beginning of 2025 another therapy center in Spain came up in Alicante.

The therapy center Vissum - Grupo Miranza with its leading physician Dr. Lucia Rial Álvarez is also offering EYETRONIC.

Feel free to contact directly the therapy center at the email address: lucia.rial@vissum.com.

For further information about Eyetronic in Spain please also contact our local distributor VIÚ 20/20 whose CEO Elisabeth Jori Massanas is.

   

  • Second Eyetronic Therapy center in Poland (Warsaw)

We are excited to announce that another therapy center has opened up in Poland.

In December 2024 also the therapy center Warszawskie Centrum Okulistyczne LIBERMEDIC in Warsaw from Prof. Iwona Grabska-Liberek started with Eyetronic.

Feel free to contact them direclty under: kontakt@libermedic.com or take a look at their website: https://libermedic.com/.

Regarding any questions about EYETRONIC in Poland please feel free to contact MDT Medical Devices Manufacturer, our local partner in Poland.

  • First Eyetronic Therapy center in Poland (Bytom near Katowice)

We are excited to announce the start of Eyetronic in Poland!

In November 2024 the first therapy center in Poland: GlaucoMed Gabinet Okulistyczny from Adrian Smedowski MD, PhD, FEBO started with Eyetronic.

Feel free to contact them direclty under: kontakt@glaucomed.pl or take a look at their website: https://www.glaucomed.pl/

Furthermore we would like to welcome our local distributor MDT Medical Devices Manufacturer to support us in Poland.

If you have any questions about Eyetronic in Poland, please feel free to contact our partner MDT!

  • New publication regarding the topic Optic Nerv Stimulation (ONS)

In August 2024 a paper by Granata et al. was published which focusses on electrical stimulation in ophthalmology.

The title is: "Transorbital Alternating Current Stimulation in Glaucoma: State of the Art from Neurophysiological Bases to Clinical Practice".

This review article emphasizes the importance of looking at optic nerve stimulation as a therapy for neuropathic conditions, like glaucoma.

We are very happy to be able to contribute to this with our EYETRONIC Therapy.

The paper you can find following:

  • Start of EYETRONIC in Spain (A Coruña)

We are very happy that since summer 2024 the Eyetronic therapy is now also beeing offered in Spain!

The first therapy center opened in A Coruña:

If you have any questions regarding the therapy in A Coruña please feel free to contact also directly the therapy center at this following email address: atencionpaciente@vistagutierrezamoros.com.

Furthermore we would like to welcome and thank our new partner in Spain: VIÚ 20/20 whose CEO Elisabeth Jori Massanas is. Feel free to also contact them if you any questions about EYETRONIC in Spain.

  • Poster presentation of the latest Eyetronic data of Normal Tension Glaucoma (NTG) patients at the World Ophthalmology Congress (WOC) in Vancouver, August 2024

We are very happy that the latest Eyetronic data of Normal Tension Glaucoma (NTG) patients could be presented with a poster at the 39th World Ophthalmology Congress (WOC) in Vancouver in August 2024.

This poster you can find in the following.

  • Presentation of Eyetronic at the Congress of the European Glaucoma Society (EGS) in Dublin, June 2024

We are very happy that we were able to present Eyetronic at the 16th congress of the European Glaucoma Society (EGS) in Dublin in June 2024.

At the congress there had been a poster presentation about the latest long-term PMCF data of Normal tension glaucoma (NTG) patients beeing treated with Eyetronic.

This poster as well as some impressions about the congress you can find in the following.

     

 

  • Abstract Presentation of latest Eyetronic Data at World Ophthalmology Congress (WOC) in Vancouver in August 2024

We are delighted to share the news that the Eyetronic abstract with the 90-day follow-up results from Normal Tension Glaucoma (NTG) patients was accepted to be presented at the upcoming World Ophthalmology Congress (WOC), which will take place in Vancouver in August 2024.

 

  • Abstract Presentation of latest Eyetronic Data at European Glaucoma Society (EGS) Congress in Dublin in June 2024

We are excited to announce that the abstract with the latest 12-month Eyetronic data from Normal Tension Glaucoma (NTG) patients was accepted to be presented at the upcoming European Glaucoma Society (EGS) Congress in Dublin, June 01-04, 2024.

 

  • Eyetronic Presentation at LSI USA 2024 investor conference, March 2024

Last week our CEO, Karl Schweitzer, had the opportunity to present the Eyetronic Therapy at the LSI USA 2024 investor conference (LSI).

Following you can find the presentation given in Dana Point, California.

 

We are very happy that the Workshop Glaucoma from Carl Erb, MD, PhD was again very well received and we were able to be part of it.

Attached you can find our translated presentation about the Eyetronic Therapy given on this occasion.

  • Start of Eyetronic in Slovakia (Banská Bystrica)

We are very happy that we could present Eyetronic at the 10th World Glaucoma Congress (WGC) in Rome.

We are very happy to add another country that is offering EYETRONIC: Slovakia.

Since the end of 2023 patients can be treated at the therapy center Viziocum by Dr. Mária Prazenicova in Banská Bystrica.

If you have any questions regardind the treatment in Slovakia please feel free to also directly contact the therapy center at the following email address: viziocum@gmail.com or visit their website: https://www.viziocum.sk/

  • Presentation of Eyetronic at the World Glaucoma Congress (WGC) in Rome June/July 2023

We are very happy that we could present Eyetronic at the 10th World Glaucoma Congress (WGC) in Rome.

Please also take a look at the poster which had been presented at the WGC in Rome and shows recent data on electrical optic nerve stimulation with Eyetronic in normal tension glaucoma (NTG) patients.

    

  • Eyetronic Presentation at the 39th Workshop Glaucoma in Januar 2023

We are very happy that we were able to participate again at the Workshop Glaucoma from Carl Erb, MD, PhD.

Attached you can find the translated presentation about the Eyetronic Therapy.

  • Presentation of Eyetronic System at DOC in Nuremberg, June 2022

In June 2022 we could present the Eyetronic System at the 34th International Congress of German Ophthalmic Surgery (DOC) in Nuremberg at the booth of our partner Polytech Domilens GmbH.

Attached you can find some pictures from the booth.

     

  • Publication of Eyetronic Data in scientific Journal Bioelectronic Medicine

The newest data from the Eyetronic Therapy had been published in the scientific Journal Bioelectronic Medicine.

Attached you can find the publication.

  • Eyetronic Presentation at the 11th annual Glaucoma 360 New Horizons Forum in San Francisco, USA, February 2022

We are happy that we could present the Eyetronic Therapy at the 11th annual Glaucoma 360 New Horizons Forum in San Francisco, USA at February 13th 2022.

Attached you can find a presentation about the Eyetronic Therapy in english.

  • Eyetronic Presentation at the 37th Workshop Glaucoma in Januar 2022

We are happy that we had been a part of the 37th Workshop Glaucoma in January 2022 from Carl Erb, MD, PhD.

Attached you can find a presentation about the Eyetronic Therapy in german.

Disclaimer Privacy Notice
This Seite uses Cookies. By visiting this site, you agree to the use of cookies. More information Ok